Lotemax
Company: Bausch & Lomb, Pharmos
Approval Status: Approved March 1998
Treatment for: post-operative eye inflammation
Areas: Ophthalmology
General Information
Other Useful Resources
Lotemax is a topical, site-specific steroid that will be used to treat post-operative eye inflammation such as that experienced following cataract surgery. The new prescription eye drop will also be used for various other inflammatory eye conditions.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
